Safety and Efficacy of a Monoclonal Antibody for Treatment of Rheumatoid Arthritis.
Status:
Completed
Trial end date:
2003-08-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether a humanized monoclonal antibody
(efalizumab) is safe and effective in the treatment of rheumatoid arthritis.